Published on GHDx (https://ghdx.healthdata.org)

SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions. Preprint

General Info

Geography 
Germany (DEU)
Coverage type 
Country
Time period covered 
July, 2020 - February, 2021
Data type
Scientific literature
Keywords 
Blood tests, COVID-19, Disease outbreaks, Infectious diseases, Medical tests

Citation

Authors 
Gornyk D, Harries M, Glöckner S, Strengert M, Kerrinnes T, Bojara G, Castell S, Frank K, Gubbe K, Heise J-K, Hernandez P, Kappert O, Kern W, Illig T, Klopp N, Maaß H, Ortmann J, Kessel B, Roller G, Schlüter M, Tonn T, Ziemons M, Kemmling Y, Lange B, Krause G
Journal 
medRxiv
Pages 
2021050421256597
Publication year 
2021
Suggested citation 
Gornyk D, Harries M, Glöckner S, Strengert M, Kerrinnes T, Bojara G, Castell S, Frank K, Gubbe K, Heise J-K, Hernandez P, Kappert O, Kern W, Illig T, Klopp N, Maaß H, Ortmann J, Kessel B, Roller G, Schlüter M, Tonn T, Ziemons M, Kemmling Y, Lange B, Krause G. SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions. Preprint. medRxiv. 2021; 2021050421256597.
Source URL:https://ghdx.healthdata.org/record/sars-cov-2-seroprevalence-germany-population-based-sequential-study-five-regions-preprint